Read the latest news and updates from NCATS.

Is this email not displaying correctly?
View it in your browser.

National Center for Advancing Translational Sciences | Catalyzing Innovation
Volume 05 • Issue 06 • June 23, 2016

Director's Message

Director's photo

A colleague here at NCATS received devastating news last year: Her 4-month-old grandson had been diagnosed with a rare brain tumor. The cancer failed to respond to first- and second-line chemotherapy, but molecular testing of the tumor revealed...


Connect with NCATS


Top Story

Hospital staff in the clinic.

NCATS SMART IRB Reliance Platform

Through its Clinical and Translational Science Awards Program, NCATS is developing a Streamlined, Multisite, Accelerated Resources for Trials (SMART) Institutional Review Board (IRB) Reliance Platform to assist researchers nationwide with multisite studies. SMART IRB Reliance also will serve as a model for NIH’s new single IRB policy. Read more >

Twitter logo

Dr. Austin participates in panel discussion at “Targeted Cures” event.

Austin Participates in Rare Diseases Policy Discussion

On May 11, 2016, NCATS Director Christopher P. Austin, M.D., participated in “Targeted Cures: A Policy Discussion on Treating Patients with Rare Diseases,” hosted by The Hill. Austin emphasized how NCATS is working to understand the scientific and operational challenges that slow the development of new interventions to improve human health. Read more >

Twitter logo

UCLA scientists.

CTSA Program Scientists Visualize Enzyme in Cancer, Aging

With support from NCATS’ Clinical and Translational Science Award Program, scientists at the University of California, Los Angeles recently produced the clearest-ever image of telomerase, an enzyme involved in cancer and aging. This knowledge could inform the development of anti-cancer and anti-aging therapies. Read more >

Twitter logo

NCATS’ Dr. Stephen Groft (left) shakes hands with Pope Francis.

Groft and Pope Francis Participate in Regenerative Medicine Event

NCATS’ Stephen Groft, Pharm.D., moderated a panel on gene and stem cell therapies to treat rare diseases at the Third International Regenerative Medicine Conference in Vatican City, April 28-30, 2016. Groft emphasized the role of patients and families in finding solutions. Read more >

Twitter logo

Portraits of Drs. Shah and Boxer

Meet More NCATS Staff

Monica R. Shah, M.D., M.H.S., M.S.J., is director of NCATS’ Trial Innovation Network in the Division of Clinical Innovation. Matthew B. Boxer, Ph.D., is a chemistry team leader in NCATS’ Division of Pre-Clinical Innovation. Learn more about these and other NCATS staff members via NCATS Staff Profiles >

Twitter logo

Discover How to Collaborate with NCATS Scientists

Research Opportunities and Announcements Highlights

More From NCATS

NCATS in the News


like us on Facebook |  follow us on Twitter |  forward to a friend |  watch us on YouTube

National Center for Advancing Translational Sciences
National Institutes of Health
6701 Democracy Boulevard, 9th Floor
Bethesda, MD 20892

For language access assistance, contact
the NCATS Public Information Officer.

Add us to your address book | Unsubscribe
NIH, National Center for Advancing Translational Sciences